Reno De Medici S.p.A. Logo

Reno De Medici S.p.A.

0K69.L

(0.0)
Stock Price

0,82 EUR

0% ROA

-4.81% ROE

0x PER

Market Cap.

0,00 EUR

0% DER

0% Yield

-30.72% NPM

Reno De Medici S.p.A. Stock Analysis

Reno De Medici S.p.A. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Reno De Medici S.p.A. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Reno De Medici S.p.A. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Reno De Medici S.p.A. Technical Stock Analysis
# Analysis Recommendation

Reno De Medici S.p.A. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Reno De Medici S.p.A. Revenue
Year Revenue Growth
2012 24.859.390.285
2013 24.495.723.602 -1.48%
2014 24.607.599.702 0.45%
2015 9.390.351.651 -162.05%
2016 12.739.789.177 26.29%
2017 13.476.449.273 5.47%
2018 12.757.471.649 -5.64%
2019 7.174.702.690 -77.81%
2020 9.868.872.027 27.3%
2021 2.923.145.906 -237.61%
2022 3.276.396.927 10.78%
2023 3.773.524.844 13.17%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Reno De Medici S.p.A. Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Reno De Medici S.p.A. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 856.167.439
2013 628.757.727 -36.17%
2014 559.066.967 -12.47%
2015 193.370.863 -189.12%
2016 599.280.863 67.73%
2017 311.594.202 -92.33%
2018 270.968.408 -14.99%
2019 132.358.063 -104.72%
2020 305.772.711 56.71%
2021 124.652.497 -145.3%
2022 113.116.180 -10.2%
2023 124.139.576 8.88%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Reno De Medici S.p.A. EBITDA
Year EBITDA Growth
2012 1.762.166.951
2013 1.751.630.112 -0.6%
2014 1.855.906.696 5.62%
2015 616.969.176 -200.81%
2016 629.091.244 1.93%
2017 860.809.178 26.92%
2018 917.264.226 6.15%
2019 391.351.943 -134.38%
2020 693.572.611 43.57%
2021 237.108.779 -192.51%
2022 170.620.058 -38.97%
2023 66.048.620 -158.32%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Reno De Medici S.p.A. Gross Profit
Year Gross Profit Growth
2012 6.715.603.124
2013 6.395.122.365 -5.01%
2014 6.319.413.094 -1.2%
2015 2.290.914.599 -175.85%
2016 2.926.027.229 21.71%
2017 3.317.632.850 11.8%
2018 2.998.734.275 -10.63%
2019 1.894.063.790 -58.32%
2020 2.647.398.620 28.46%
2021 781.275.222 -238.86%
2022 813.755.533 3.99%
2023 947.757.928 14.14%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Reno De Medici S.p.A. Net Profit
Year Net Profit Growth
2012 513.146.692
2013 445.422.982 -15.2%
2014 454.100.827 1.91%
2015 155.252.063 -192.49%
2016 -21.819.969 811.51%
2017 137.379.227 115.88%
2018 263.735.695 47.91%
2019 -79.365.079 432.31%
2020 210.266.877 137.74%
2021 -538.068 39178.12%
2022 -194.643.059 99.72%
2023 635.817.448 130.61%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Reno De Medici S.p.A. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 2
2013 2 0%
2014 2 0%
2015 1 0%
2016 0 0%
2017 1 0%
2018 1 0%
2019 0 0%
2020 1 0%
2021 0 0%
2022 -1 0%
2023 2 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Reno De Medici S.p.A. Free Cashflow
Year Free Cashflow Growth
2012 1.947.915.060
2013 1.370.141.417 -42.17%
2014 1.358.540.256 -0.85%
2015 770.201.702 -76.39%
2016 -789.514.121 197.55%
2017 148.852.657 630.4%
2018 676.258.621 77.99%
2019 -330.148.779 304.83%
2020 472.330.265 169.9%
2021 303.649.897 -55.55%
2022 -305.300.192 199.46%
2023 -77.587.235 -293.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Reno De Medici S.p.A. Operating Cashflow
Year Operating Cashflow Growth
2012 2.586.895.289
2013 2.071.301.549 -24.89%
2014 1.877.351.392 -10.33%
2015 1.169.313.104 -60.55%
2016 -400.749.869 391.78%
2017 572.161.835 170.04%
2018 1.102.213.726 48.09%
2019 282.380.454 -290.33%
2020 913.081.988 69.07%
2021 489.283.472 -86.62%
2022 -40.858.018 1297.52%
2023 -22.878.287 -78.59%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Reno De Medici S.p.A. Capital Expenditure
Year Capital Expenditure Growth
2012 638.980.229
2013 701.160.132 8.87%
2014 518.811.136 -35.15%
2015 399.111.402 -29.99%
2016 388.764.252 -2.66%
2017 423.309.178 8.16%
2018 425.955.105 0.62%
2019 612.529.233 30.46%
2020 440.751.723 -38.97%
2021 185.633.575 -137.43%
2022 264.442.174 29.8%
2023 54.708.948 -383.36%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Reno De Medici S.p.A. Equity
Year Equity Growth
2012 5.402.953.868
2013 5.382.335.506 -0.38%
2014 5.340.105.342 -0.79%
2015 3.370.610.657 -58.43%
2016 3.871.354.374 12.93%
2017 3.937.499.999 1.68%
2018 3.399.116.574 -15.84%
2019 3.370.652.335 -0.84%
2020 3.236.222.897 -4.15%
2021 2.937.853.107 -10.16%
2022 2.597.699.843 -13.09%
2023 998.488.042 -160.16%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Reno De Medici S.p.A. Assets
Year Assets Growth
2012 17.003.713.936
2013 16.092.387.163 -5.66%
2014 17.059.819.415 5.67%
2015 11.925.630.473 -43.05%
2016 13.896.247.581 14.18%
2017 14.404.287.437 3.53%
2018 16.012.192.285 10.04%
2019 14.548.191.269 -10.06%
2020 10.262.063.386 -41.77%
2021 8.867.904.225 -15.72%
2022 8.292.475.313 -6.94%
2023 4.512.990.887 -83.75%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Reno De Medici S.p.A. Liabilities
Year Liabilities Growth
2012 11.600.760.068
2013 10.710.051.656 -8.32%
2014 11.719.714.072 8.62%
2015 8.555.019.815 -36.99%
2016 10.024.893.206 14.66%
2017 10.466.787.437 4.22%
2018 12.613.075.709 17.02%
2019 11.177.538.934 -12.84%
2020 7.025.840.488 -59.09%
2021 5.930.051.117 -18.48%
2022 5.694.775.469 -4.13%
2023 3.514.502.844 -62.04%

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Reno De Medici S.p.A. Dividends
Year Dividends Growth
2018 0
2019 0 0%
2020 0 0%

Reno De Medici S.p.A. Profile

About Reno De Medici S.p.A.

Reno De Medici S.p.A. produces and distributes carton boards primarily in Italy, Portugal, Spain, Germany, France, and Internationally. The company operates through White Lined Chipboard, Folding Box Board, and Specialties segments. It offers coated recycled carton boards; folding virgin fiber carton boards; carton boards for specialties and luxury packaging; and specialty board for luxury packaging and publishing industry. The company also offers various forms of carton boards, such as Vincicoat, Serviliner, Vinciliner, Vinciflexo, Flexoliner, Rochcoat, Hermicoat, Rochblanc, Rochcoat Blanc, Rochfreeze, Rochperle, Blanc II Grey, Hermiwhite, Hermikraft, Vinciavana, Vincibright, Vincibright Special, Vinciwhite, Triplex Blanco, Triplex Gris, Triplex Gris EB, and Triplex Madera. The company was founded in 1967 and is headquartered in Milan, Italy.

CEO
Mr. Michele Bianchi
Employee
1.729
Address
viale Isonzo 25
Milan, 20135

Reno De Medici S.p.A. Executives & BODs

Reno De Medici S.p.A. Executives & BODs
# Name Age

Reno De Medici S.p.A. Competitors